Insider: Lunger John Chief Patient Supply Officer - Adaptimmune Therapeutics PLC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 7,510 | 0 | 7,510 |
| Value | $1,120.49 | $0.00 | $1,120.49 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 01/17/2025 | DDS | 5,584 | Direct | COM | $0.58 | $3,243.19 | 7,510 |
| 01/15/2025 | DDS | 9,803 | Direct | COM | $0.57 | $5,634.76 | 13,756 |
| 01/13/2025 | DDS | 4,268 | Direct | COM | $0.59 | $2,509.16 | 5,845 |
| 01/13/2025 | DDS | 5,471 | Direct | COM | $0.59 | $3,216.40 | 7,623 |
| 01/17/2024 | DDS | 5,309 | Direct | COM | $0.67 | $3,572.96 | 7,785 |
| 01/17/2024 | DDS | 12,805 | Direct | COM | $0.67 | $8,617.77 | 19,015 |
| 01/16/2024 | DDS | 4,681 | Direct | COM | $0.79 | $3,697.99 | 7,023 |
| 01/12/2024 | DDS | 5,220 | Direct | COM | $0.85 | $4,458.40 | 7,874 |
| 01/11/2024 | DDS | 4,009 | Direct | COM | $0.84 | $3,354.33 | 6,104 |
| 08/01/2023 | DDS | 3,096 | Direct | COM | $0.91 | $2,803.74 | 4,718 |
| 01/17/2023 | DDS | 4,440 | Direct | COM | $1.86 | $8,249.52 | 7,264 |
| 01/12/2023 | DDS | 4,973 | Direct | COM | $1.71 | $8,483.94 | 8,121 |
| 01/11/2023 | DDS | 3,843 | Direct | COM | $1.75 | $6,712.95 | 6,270 |
| 01/04/2023 | DDS | 1,100 | Direct | COM | $1.69 | $1,863.40 | 1,725 |
| 08/01/2022 | DDS | 2,983 | Direct | COM | $1.77 | $5,290.35 | 4,829 |
| 07/05/2022 | DDS | 1,973 | Direct | COM | $1.68 | $3,310.89 | 3,104 |
| 01/18/2022 | DDS | 4,368 | Direct | COM | $3.19 | $13,941.78 | 7,336 |
| 01/12/2022 | DDS | 1,076 | Direct | COM | $3.54 | $3,813.45 | 1,749 |
| 01/11/2022 | DDS | 3,770 | Direct | COM | $3.56 | $13,408.76 | 6,343 |
| 01/04/2022 | DDS | 1,070 | Direct | COM | $4.06 | $4,348.69 | 1,755 |
| 08/02/2021 | DDS | 2,939 | Direct | COM | $3.58 | $10,535.73 | 4,873 |
| 07/02/2021 | DDS | 1,907 | Direct | COM | $4.26 | $8,133.16 | 3,170 |
| 01/19/2021 | DDS | 4,358 | Direct | COM | $5.67 | $24,707.68 | 7,346 |
| 01/12/2021 | DDS | 1,058 | Direct | COM | $6.15 | $6,509.03 | 1,767 |
| 01/04/2021 | DDS | 1,065 | Direct | COM | $5.33 | $5,674.21 | 1,760 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research